Establishment and validation of a population pharmacokinetic model for apatinib in patients with tumors
Abstract Objective This study aimed to develop a population pharmacokinetic (PPK) model for oral apatinib in Chinese oncology patients and investigate the factors influencing the pharmacokinetics of apatinib. Methods We gathered 199 blood concentration monitoring data points from 91 inpatient oncolo...
Saved in:
| Main Authors: | Li’an Zuo, Jing Ling, Nan Hu, Rong Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-024-13118-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment and application of population pharmacokinetics model of vancomycin in infants with meningitis
by: Jianwen Xu, et al.
Published: (2022-01-01) -
External validation of population pharmacokinetic models of gentamicin in paediatric population from preterm newborns to adolescents
by: Črček Mateja, et al.
Published: (2023-06-01) -
An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction
by: Ryutaro Iwama, et al.
Published: (2024-12-01) -
Development and Validation of a Population Pharmacokinetics Model of Perampanel for Pediatric Epilepsy Patients for Optimized Dosing
by: Yu L, et al.
Published: (2025-04-01) -
A Pragmatic Approach to Handling Censored Data Below the Lower Limit of Quantification in Pharmacokinetic Modeling
by: Marie Wijk, et al.
Published: (2025-06-01)